This inventor holds 1 USPTO granted patent. Top assignee: Hemarus Therapeutics Limited. Active years: 2017.
Company Filing History:
Years Active: 2017
Introduction
Vvs Sailesh Bavirisetti, based in Hyderabad, Telangana, India, is an accomplished inventor known for his contributions to the field of biotechnology. With one patent to his name, he has made significant strides in improving the extraction process of immunoglobulins from human plasma.
Latest Patents
His notable patent, "Process for Increased Yield of Immunoglobulin from Human Plasma," introduces a method for the large-scale production of human immunoglobulins (IgG) with high yields. This innovative process utilizes an improved all-chromatography scheme that eliminates the need for ethanol precipitation, allowing for the effective extraction of immunoglobulins while leaving other therapeutic proteins intact for separate extraction. The yields from this process reach impressive levels of 7 to 8 grams of IgG per liter of plasma. Furthermore, the method includes steps for viral inactivation and removal, ensuring that the purified immunoglobulin protein meets pharmacopoeial limits, making it suitable for therapeutic administration such as normal intravenous immunoglobulin (IVIG).
Career Highlights
Vvs Sailesh Bavirisetti is affiliated with Hemarus Therapeutics Limited, a company dedicated to advancing healthcare solutions through innovative therapeutic methods. His work in this organization showcases his commitment to transforming and enhancing treatment methodologies within the pharmaceutical sector.
Collaborations
Throughout his career, Vvs has collaborated with talented professionals such as Ashok Kumar Nuvula and Zinia Chakraborty, contributing to a dynamic team environment focused on scientific research and development. These collaborations underscore the importance of teamwork in driving innovation and achieving significant advancements in healthcare.
Conclusion
In summary, Vvs Sailesh Bavirisetti is a noteworthy figure in the realm of biotechnology, particularly for his patented process that vastly improves the extraction of immunoglobulins from human plasma. His work not only enhances yield efficiency but also ensures the therapeutic viability of immunoglobulins, thereby making a considerable impact in the field of medicine. With continued collaboration and innovation, he is poised to contribute even further to healthcare advancements in the future.